Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5603961 | 0.73 | CYP2A6 (0.33) | — | |
| SCHEMBL223499 | 0.73 | PNMT (0.38) | — | |
| SCHEMBL814237 | 0.73 | — | — | |
| SCHEMBL1456915 | 0.73 | PNMT (0.38) | — | |
| SCHEMBL3414198 | 0.72 | ACHE (0.33) | ACHETSHR | |
| SCHEMBL5602318 | 0.71 | NPC1 (0.32) | — | |
| SCHEMBL6754203 | 0.71 | DRD1 (0.49) | ACHETSHR | |
| SCHEMBL29133072 | 0.69 | TSHR (0.47) | TSHR | |
| SCHEMBL6312706 | 0.68 | PARP1 (0.33) | ACHE | |
| SCHEMBL5603449 | 0.67 | IDO1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114075131-A | TADF material, preparation method thereof and organic electroluminescent device thereof | 吉林奥来德光电材料股份有限公司 | 2022-02-22 | — | — | CN | claimed |
| EP-3386511-B1 | METHODS FOR TREATING HUNTINGTON'S DISEASE | PTC THERAPEUTICS INC (US) | 2021-05-12 | — | — | EP | claimed |
| CN-107522652-B | Organic light-emitting element, and light-emitting material and compound used for same | 九州有机光材股份有限公司 | 2021-01-05 | — | — | CN | claimed |
| US-10874672-B2 | Methods for treating Huntington's disease | PTC THERAPEUTICS, INC. (US) | 2020-12-29 | — | — | US | claimed |
| CN-110850680-A | Curable composition, display element, and method for forming cured film | JSR株式会社 | 2020-02-28 | — | — | CN | claimed |
| US-10276803-B2 | Organic light-emitting device, and light-emitting material and compound used therefor | KYULUX, INC. (JP) | 2019-04-30 | — | — | US | claimed |
| EP-2851408-B1 | ORGANIC LIGHT EMITTING DEVICE, AND LIGHT EMITTING MATERIAL AND COMPOUND USED THEREFOR | KYULUX INC (JP) | 2018-11-21 | — | — | EP | claimed |
| US-20170256720-A1 | ORGANIC LIGHT-EMITTING DEVICE, AND LIGHT-EMITTING MATERIAL AND COMPOUND USED THEREFOR | KYULUX, INC. (JP) | 2017-09-07 | — | — | US | claimed |
| EP-2750678-B1 | ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE | PTC THERAPEUTICS INC (US) | 2017-03-22 | — | — | EP | claimed |
| US-9502668-B2 | Organic light-emitting device, and light-emitting material and compound used therefor | KYULUX, INC. (JP) | 2016-11-22 | — | — | US | claimed |
| US-20060122156-A1 | Heteroaryl compounds | SYNTA PHARMACEUTICALS CORP. (US) | 2006-06-08 | — | — | US | claimed |
| WO-2006053109-A1 | HETEROARYL COMPOUNDS | SYNTA PHARMACEUTICALS CORP. (US) | 2006-05-18 | — | — | WO | claimed |
| US-20050261449-A1 | Heterocyclic substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENT INC. | 2005-11-24 | — | — | US | claimed |
| WO-2005105864-A1 | HETEROCYCLIC SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-11-10 | — | — | WO | claimed |
| EP-1117656-B1 | GREY COLOURING PHOTOCHROMIC FUSED PYRANS | JAMES ROBINSON LTD (GB) | 2002-05-29 | — | — | EP | claimed |
| US-6387512-B1 | FOR COLORING INKS, FUELS, PLASTICS OR GLASS | JAMES ROBINSON LIMITED (GB) | 2002-05-14 | — | — | US | claimed |
| EP-1117656-A1 | GREY COLOURING PHOTOCHROMIC FUSED PYRANS | JAMES ROBINSON LIMITED (GB) | 2001-07-25 | — | — | EP | claimed |
| WO-2000018755-A1 | GREY COLOURING PHOTOCHROMIC FUSED PYRANS | JAMES ROBINSON LIMITED (GB) | 2000-04-06 | — | — | WO | claimed |
| EP-0471236-B1 | Imidazopyridine derivatives and their use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1995-03-15 | — | — | EP | claimed |
| EP-0471236-A1 | Imidazopyridine derivatives and their use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-02-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10276803-B2 | Organic light-emitting device, and light-emitting material and compound used therefor | CRY1, WEE1, OR51E2 | ACHE 1643/4885TSHR 3283/4885 |
| US-20060122156-A1 | Heteroaryl compounds | IL2, CCL11, IL4 | ACHE 3465/4885TSHR 3956/4885 |
| US-20170256720-A1 | ORGANIC LIGHT-EMITTING DEVICE, AND LIGHT-EMITTING MATERIAL AND COMPOUND USED THEREFOR | CRY1, WEE1, OR51E2 | ACHE 1643/4885TSHR 3283/4885 |
| US-10874672-B2 | Methods for treating Huntington's disease | HTT, HYPK, FH | ACHE 67/4885TSHR 3678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.